Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Team Inc (TISI)
NYSEIndustrialsSpecialty Business ServicesSnapshot 2026-11-05
$22.70-5.50%
Close 2026-11-05 · 1-day change
NYSEIndustrialsSpecialty Business ServicesSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for TISI yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
5 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Adjusted EBITDA between $68 million and $73 million in FY26 | Management targets adjusted EBITDA up to $73 million. | Intact | Adjusted EBITDA falls below $68 million in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 2 supplied quarters. Management reported: “• Increased Adjusted EBITDA 1 to $7.7 million (3.6% of consolidated revenue), up 45.2% from $5.3 million (2.7% of consolidated revenue) in the 2025 first quarter.” “2026 Outlook For fiscal year 2026, the Company has provided the following operating and cash flow guidance: • Total Company Revenue of $920 million to $945 million, an increase of approximately 4% at the midpoint of guidance compared to 2025; • Gross Margin of between $240 million and $260 million, an increase of approximately 8% at the midpoint of guidance compared to 2025; • Adjusted EBITDA of between $68 million and $73 million, an increase of approximately 16% at the midpoint of guidance compared to 2025; • Capital expenditures of between $13 million to $14 million.” |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a higher-risk industrial business with a turnaround-like improvement case, rather than a proven durable compounder. Its long-term thesis is on watch: recent results show progress toward 2026 goals, while performance remains below its industry cohort.
The valuation evidence is mixed: TISI is described as cheap versus peers, but the model has low confidence and the expectations gap is negative. The priced-in assessment is tagged justified, with low fragility, so the evidence does not point to a clear mismatch between valuation and expectations.
Near term, management is on track with its 2026 revenue, adjusted EBITDA, and gross profit goals; first-quarter results showed growth in all three measures. However, repeated earnings misses create elevated risk of another miss, and the industrial sector backdrop is a headwind.
The multi-year case hinges on continued delivery against 2026 guidance and whether improving adjusted EBITDA translates into sustained progress. Near term, a guidance cut would be a meaningful negative; results and guidance from CTAS, CPRT, and ROL may signal whether industrial sector momentum is strengthening or fading.
Over the next one to three years, TISI has evidence of operating progress but also a fragile execution record, with an elevated near-term miss risk and a headwind from its sector. The thesis remains on watch and depends on meeting guidance while sustaining improvement. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Capital expenditures capped between $13 million and $14 million in FY26 | Capital spending is controlled between $13 million and $14 million. | Intact | Capital expenditures exceed $14 million in FY26 | Capital expenditures: $3.982M FY2026-Q2; GAAP. Published target: <= $14 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 10, 20263,982,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 2 supplied quarters. Management reported: “2026 Outlook For fiscal year 2026, the Company has provided the following operating and cash flow guidance: • Total Company Revenue of $920 million to $945 million, an increase of approximately 4% at the midpoint of guidance compared to 2025; • Gross Margin of between $240 million and $260 million, an increase of approximately 8% at the midpoint of guidance compared to 2025; • Adjusted EBITDA of between $68 million and $73 million, an increase of approximately 16% at the midpoint of guidance compared to 2025; • Capital expenditures of between $13 million to $14 million.” Delivery assessment Nov 5, 2026 |
Gross margin at least $240 million in FY26 | Profit margins should improve with gross margin near $250 million. | Intact | Gross margin falls below $240 million in FY26 | Gross margin: 23.79% FY2026-Q2; GAAP. Published target: >= $240 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 10, 202623.787159 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 2 supplied quarters. Management reported: “• Generated gross margin of $50.2 million, up $2.9 million, or 6.1%, over the first quarter of 2025.” “2026 Outlook For fiscal year 2026, the Company has provided the following operating and cash flow guidance: • Total Company Revenue of $920 million to $945 million, an increase of approximately 4% at the midpoint of guidance compared to 2025; • Gross Margin of between $240 million and $260 million, an increase of approximately 8% at the midpoint of guidance compared to 2025; • Adjusted EBITDA of between $68 million and $73 million, an increase of approximately 16% at the midpoint of guidance compared to 2025; • Capital expenditures of between $13 million to $14 million.” Delivery assessment Nov 5, 2026 |
Stable executive leadership without further major departures | A supporting condition in Team Inc's published investment case. The stated target is No further CEO or CFO departures in next 12 months. | Under Pressure | Another CEO or CFO departure occurs within next 12 months | CFO departure confirmed vs no departure target CFO Nelson Haight departed June 2026; CAO transitioned October 2026. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue reaches at least $920 million in FY26 | A primary condition in Team Inc's published investment case. The stated target is >= $920 million. | Intact | Revenue falls below $920 million in FY26 | Revenue: $228.678M FY2026-Q2; GAAP. Published target: >= $920 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 10, 2026228,678,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 2 supplied quarters. Management reported: “First Quarter 2026 Highlights: • Grew revenue to $215.1 million, up $16.4 million, or 8.3%, over the first quarter of 2025.” “2026 Outlook For fiscal year 2026, the Company has provided the following operating and cash flow guidance: • Total Company Revenue of $920 million to $945 million, an increase of approximately 4% at the midpoint of guidance compared to 2025; • Gross Margin of between $240 million and $260 million, an increase of approximately 8% at the midpoint of guidance compared to 2025; • Adjusted EBITDA of between $68 million and $73 million, an increase of approximately 16% at the midpoint of guidance compared to 2025; • Capital expenditures of between $13 million to $14 million.” Delivery assessment Nov 5, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-13.60 → $-13.60 · observed estimates
$1.26B → $1.26B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-07-25 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-07-26 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-07-27 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-07-28 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-07-29 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-07-30 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-07-31 | $-13.60 | $1,259,425,000 | 5 / 6 |
| 2026-08-01 | $-13.60 | $1,259,425,000 | 5 / 6 |
| 2026-08-02 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-03 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-04 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-05 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-06 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-08 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-09 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-10 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-12 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-13 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-14 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-15 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-16 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-17 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-18 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-19 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-20 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-21 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-22 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-23 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-24 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-25 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-26 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-27 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-28 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-29 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-30 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-08-31 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-01 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-02 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-03 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-04 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-05 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-06 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-07 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-08 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-09 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-10 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-11 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-12 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-13 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-14 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-15 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-16 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-17 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-18 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-19 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-20 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-21 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-22 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-23 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-24 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-25 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-26 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-27 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-28 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-29 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-09-30 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-01 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-02 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-03 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-04 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-05 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-06 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-07 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-08 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-09 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-10 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-11 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-12 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-13 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-14 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-15 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-16 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-17 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-18 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-19 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-20 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-21 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-22 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-23 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-24 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-25 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-26 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-27 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-28 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-29 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-30 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-10-31 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-11-01 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-11-02 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-11-03 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-11-04 | $-13.60 | $1,259,425,000 | 1 / 1 |
| 2026-11-05 | $-13.60 | $1,259,425,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Monthly analyst history is unavailable.
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 11, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings5 of 5 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.